Newcastle Disease Virus Virotherapy: Unveiling Oncolytic Efficacy and Immunomodulation.

This particular concentration was deemed marginally significant ( p = 0.049) and ( p = 0.025) for HCT116 and HT-29 cells, respectively, suggesting that there is no genuine distinction between lower concentrations of the treatments concerning the viability of both, as depicted in Figure 2 . 3.3.

also in 26,082 other papers